Florida’s Citrus Collapse: How Greening Bacteria Turned the Orange State’s Groves into Ghost Orchards

Florida’s orange groves, once sprawling empires that fueled breakfast tables nationwide, now stand as skeletal reminders of a industry’s swift unraveling. Production has plummeted from 242 million 90-pound boxes in 2023 to a projected 12 million for the 2026 harvest—the state’s worst output in over a century, according to USDA estimates. Every commercial tree in the state carries the bacterial scourge known as citrus greening, or huanglongbing (HLB), spread by the Asian citrus psyllid. Leaves yellow and droop. Fruit stays small, bitter, green-tinged. Trees choke from within. No cure exists. Researchers agree: 100% infection rate.

The psyllid arrived around 1998, the bacteria in 2005. By now, devastation. Clive Bock, a USDA agricultural researcher, warned Slate it could creep along the Gulf Coast. Rick Dantzler, COO of the Citrus Research and Development Foundation, called 2026 a “dumpster fire of a year” at the Florida Citrus Show, as reported by Futurism. Hurricanes, sprawl, trade spats—all piled on. But HLB delivered the knockout.

Growers fight back with desperation tactics. Trunk injections of oxytetracycline, approved in 2023, suppress bacteria in some groves. Yet results vary; the antibiotic hits the xylem more than the phloem where the pathogen hides, per the 2025–2026 Florida Citrus Production Guide from University of Florida’s IFAS. Psyllid sprays continue, relentless. Protective screens shield young trees. Nutrition tweaks—enhanced potassium, micronutrients—buy time. Still, yields crash. Trees die in 5 to 15 years.

University of Florida leads the charge on tolerance. In Fort Pierce, the Millennium Block trial wraps up harvests from 2022 to 2026, testing greening-tolerant varieties. Results due soon. Felipe Zambon, a researcher there, notes production’s plunge to 1920s levels. “We are seeing decline… since the 1920s,” he told CBS12. Standout: the 914 pomelo hybrid. Tastes like grapefruit. Survives infection, pumps out quality fruit. Not a cure. Tolerance.

Gene editing accelerates hope. CRISPR snips vulnerability genes. Soilcea, licensing UF tech, eyes commercial trees by late 2026 or 2027. CEO Yianni Lagos: “It’s going to take four, five years… before it’s at full production.” Field trials show edited rootstocks slashing bacteria by 17,000 times, per IR-4 Project. UF’s Crop Transformation Center hunts tolerance genes with AI, targeting proteins bacteria exploit. Matt Joyner of Florida Citrus Mutual sees CRISPR oranges in stores next year, as covered by Gulf Coast News.

Biologicals emerge too. Silvec Biologics’ budwood treatment heads to full EPA review after USDA nod. Bayer backs psyllid-killing wasps like Tamarixia radiata in Brazil, eyeing Florida spread, via Bayer. Invaio’s Trecise tech injects suppressants, cutting bacteria up to 99% in Brazilian trials. Yields up 21%. Fruit drop down 31%.

But time drags. Growers like Wayne Simmons of LaBelle Fruit cling on. Fifth-generation. “My goal… is growing oranges.” Land shifts: solar farms, blueberries, homes. Acreage hits 105-year low, per News-Press. Jobs vanish—33,000 at risk statewide. Juice prices soar toward $12 a gallon.

HLB lurks global. Brazil’s groves falter, 44% infected. California, Texas watch warily. Lessons clear. Monocultures crumble fast. Pathogens outpace policy. Florida’s fall warns: diversify now. Breed resilience. Or watch empires wither.

And yet. Trials bloom. Trees endure. Growers adapt. The squeeze tightens. But seeds of recovery push through.